Nephrologists Global Market Opportunities And Strategies To 2031

This report describes and explains the nephrologists market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The nephrologists market reached a value of nearly $10,818.3 million in 2021, having grown at a compound annual growth rate (CAGR) of 3.7% since 2016. The market is expected to grow from $10,818.3 million in 2021 to $15,358.7 million in 2026 at a rate of 7.3%. The market is then expected to grow at a CAGR of 8.0% from 2026 and reach $22,558.2 million in 2031.

Growth in the historic period resulted from the increasing kidney diseases, an aging population pool, an increase in diabetes prevalence, increasing hypertension cases, public health insurance reforms, increase in pharmaceutical R&D expenditure, increased healthcare expenditure and growth in the number of healthcare facilities.

Going forward, increasing older population, a rise in healthcare expenditure, increasing prevalence of kidney diseases and increased diabetes burden will drive the growth. Factors that could hinder the growth of the nephrologists market in the future include lack of healthcare infrastructure, shortage of nephrologists and alternative treatments.

The nephrologists market is segmented by practice into owner- solo practice, owner- group practice and full-time employed. The full-time employed market was the largest segment of the nephrologists market segmented by practice, accounting for 60.0% of the total in 2021. Going forward, the full-time employed market is expected to be the fastest growing segment in the nephrologists market segmented by practice, at a CAGR of 7.4% during 2021-2026.

The nephrologists market is segmented by population density into higher density of nephrologists, median density of nephrologists and lower density of nephrologists. The median density of nephrologists market was the largest segment of the nephrologists market segmented by population density, accounting for 45.8% of the total in 2021. Going forward, the lower density of nephrologists market is expected to be the fastest growing segment in the nephrologists market segmented by population density, at a CAGR of 7.33% during 2021-2026.

The nephrologists market is segmented by application into acute and chronic kidney diseases, diabetes, fluid and electrolyte disorders, glomerulonephritis and glomerular diseases, lupus, hypertension, kidney and pancreas transplantation, kidney-related metabolic disorders, kidney stones, rare and genetic kidney diseases. The acute and chronic kidney diseases market was the largest segment of the nephrologists market segmented by application, accounting for 25.7% of the total in 2021. Going forward, the acute and chronic kidney diseases market is expected to be the fastest growing segment in the nephrologists market segmented by application, at a CAGR of 7.8% during 2021-2026.

North America was the largest region in the nephrologists market, accounting for 34.9% of the total in 2021. It was followed by Asia- Pacific, and then the other regions. Going forward, the fastest-growing regions in the nephrologists market will be Asia Pacific, and, Middle East where growth will be at CAGRs of 7.8% and 7.4% respectively. These will be followed by Western Europe, and, North America where the markets are expected to grow at CAGRs of 7.4% and 6.8% respectively.

Global economic activity is suffering a major setback due to the coronavirus outbreak and the measures being taken to control it. Due to various country-wide lockdowns, this pandemic has had a negative impact on several markets with a drop in demand for nephrologists.

Nephrologists are experts in the field of nephrology, which is a study of kidneys and the treatment of kidney diseases. Nephrologists faced a reduction in patient volume and saw a delay or disruption in research and development activities. Furthermore, clinical treatments that are considered non-urgent or non-fatal were being delayed with hospital capacities being prioritized for COVID treatment and not kidney related specialty treatments.

The global nephrologists market is fairly fragmented, with a large number of small players. The top ten competitors in the market made up to 14.98% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Mayo Clinic was the largest competitor with 2.40% share of the market, followed by Johns Hopkins Hospital with 2.25%, Mount Sinai Hospital with 2.08%, Cleveland Clinic with 2.03%, New York-Presbyterian Hospital with 1.74%, Innovative Renal Care with 1.49%, Hospitals of the University of Pennsylvania-Penn Presbyterian with 0.97%, Barnes-Jewish Hospital with 0.72%, Massachusetts General Hospital with 0.69%, and UCSF Medical Center with 0.61%.

The top opportunities in the nephrologists market segmented by practice will arise in the full-time employed segment, which will gain $2,785.2 million of global annual sales by 2026. The top opportunities in segment by population density will arise in the median density of nephrologists segment, which will gain $2,091.4 million of global annual sales by 2026. The top opportunities in segment by application will arise in the acute and chronic kidney diseases segment, which will gain $1,258.4 million of global annual sales by 2026. The nephrologists market size will gain the most in the USA at $1,316.5 million.

Market-trend-based strategies for the nephrologists market include focus on using innovative and advanced imaging technologies and tools, use of new, advanced techniques for the treatment of patients, exploring opportunities to improve treatment by offering personalized care and investment in AI solutions.

Player-adopted strategies in the nephrologists market include expanding product portfolio focusing on technology innovation, providing new products to support nephrology division, research and development for nephrologist technology and collaboration with outside companies.

To take advantage of the opportunities, the publisher reccomends the nephrologists companies to use artificial intelligence, focus on personalized nephrology, use advanced imaging technologies and tools, focus on emerging markets, focus on hospitals and clinics, offer competitive pricing, focus on patient referral systems, use search engine optimization (SEO) marketing, focus on customer reviews, focus on critical cases and focus on services for the elderly.